Evidence map›Paper›PMID 39077656›Full record

ReviewReviews in cardiovascular medicine2024

Current Balloon Devices for Ablation of Atrial Fibrillation.

Shiro Nakahara, Yuichi Hori, Reiko Fukuda, Hirotsugu Sato, Hideyuki Aoki, Yuki Kondo, Yuta Kimura, Yuji Itabashi, Tetsuya Ishikawa, Sayuki Kobayashi and 1 more

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shiro NakaharaDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Yuichi HoriDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Reiko FukudaDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Hirotsugu SatoDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Hideyuki AokiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Yuki KondoDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Yuta KimuraDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Yuji ItabashiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Tetsuya IshikawaDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Sayuki KobayashiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.
Isao TaguchiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, 343-8555 Koshigaya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balloon-based catheter ablation is a valuable option for the treatment of atrial fibrillation (AF) because contiguous lesions can be created to achieve pulmonary vein isolation (PVI), and the method is less dependent than traditional ablation methods on the operator's skill and experience. Cryoballoon ablation is used universally worldwide, with its efficacy and safety being comparable to the efficacy and safety of standard radiofrequency ablation, and the procedure can be completed in a relatively short time. Hot balloon ablation was developed in Japan. The balloon maintains its compliance even during the energy delivery, and a large areal ablation lesion is created. Furthermore, the hot balloon system is the only system for which oesophageal cooling is a standard feature. Laser balloon ablation, which is performed under direct endoscopic vision, has proven to be effective and safe for achieving a PVI. The laser balloon system provides an improved field of view and automated circumferential ablation for a rapid and effective PVI. The authors have reviewed the currently available balloon systems as used for AF ablation, i.e., PVI, and have provided detailed insight and perspectives on the currently available cryoballoon and hot balloon technologies, plus laser balloon technology.

Indexed as

atrial fibrillationcryoballoonhot balloonlaser balloon

Identifiers

PMID39077656
PMCPMC11262367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.